ARTICLE SUMMARY:
Stephen Hahn faced questions from senators weighing his nomination to be FDA’s next commissioner, and more US regulatory updates in the November 21 edition of Pathways’ Picks, MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news.
Medical devices got precious little attention during the November 20 Senate hearing to vet Stephen Hahn, who seems to have a clear path to be confirmed as the next FDA commissioner. Hahn’s confirmation hearing leads this week’s Pathways’ Picks—a rundown of medtech policy happenings and key dates that should be on your radar.
